This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Presenter: Malgorzata Mikulska, Maunank Shah, Joshua Hill, Dionysios Neofytos, , ,
Authors: Malgorzata Mikulska, Maunank Shah, Joshua Hill, Dionysios Neofytos
Appreciate the complexities of infectious complications in CAR-T cell recipients.
Dr Dionysios Neofytos is an Attending Physician at the Division of Infectious Diseases, Transplant Infectious Disease Service, University Hospital of Geneva, Geneva, Switzerland. He completed his Master of Science in Public Health at the Thomas Jefferson University, Philadelphia, USA and his training in infectious diseases and internal medicine at the Thomas Jefferson University, Philadelphia and Newton-Wellesley Hospital, Boston, USA, respectively. Upon completion of training, he joined the School of Medicine, John Hopkins University and Memorial Sloan Kettering Cancer Center – Cornell University as an Assistant Professor and Attending Physician before joining the University of Hospital Geneva. He is actively involved in clinical research in the field of invasive fungal infections in immunocompromised hosts, presenting his work at international scientific meetings and conferences and has published numerous peer-reviewed articles and books in the field of infectious diseases and hematopoietic stem cell transplantation.
Malgorzata Mikulska is Associate Professor of Infectious Diseases at the University of Genova (Department of Health Sciences, DISSAL) since 2015, and full time Infectious Diseases Consultant at the Division of Infectious Diseases, IRCCSS Ospedale Policlinico San Martino in Genova, Italy.
She obtained her medical degree at Warsaw Medical University, Poland, subsequently recognized in 2005 by the University of Genova. She completed her specialty training in Infectious Diseases at the University of Genova and obtained PhD degree at Università Cattolica di Roma, Italy.
She is an author or co-author of over 200 documents, mostly indexed in international medical journals, with H-index of 44. She is also a co-author of 10 book chapters, including the one of Prophylaxis and Empirical Therapy of Infections in Cancer Patients in “Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases”, 9th Edition. By John E. Bennett, Raphael Dolin, Martin J. Blaser. Elsevier 2020.
Her principal areas of expertise are infections in the immunocompromised patients, in particular in patients with haematological disorders and allogeneic haematopoietic stem cell transplant (HSCT) recipients, and diagnosis and treatment of invasive fungal infections.She is an active member of the following scientific societies:
Dr. Shah is an Associate Professor in the Division of Infectious Diseases at Johns Hopkins School of Medicine, and Department of Epidemiology in the Johns Hopkins School of Public Health. He is Medical Director of the Baltimore Tuberculosis Program, and is President of the US National Society of Tuberculosis Clinicians. Dr. Shah’s research involves evaluating and implementing novel HIV and tuberculosis (TB) intervention strategies in both low and high-incidence settings. He has evaluated new TB diagnostic technologies and assessed the cost-effectiveness of emerging strategies for HIV and TB care in multiple locations. He led the evidence review for the WHO Guideline Development Group for usage of Urinary LAM for diagnosis of TB, and is formerly the Maryland site PI for the CDC TB Epidemiologic Studies Consortium. He is co-inventor of the electronic directly observed therapy platform used in more than 500 health departments in the US (www.emocha.com), and has led development and implementation of an online electronic TB consultation platform for the Northeast Regional CDC funded TB Center of Excellence (Rutgers.IDCrowd.Org). He is the inventor of HIV decision support tools (www.hivassist.com). Dr. Shah serves as the Deputy Editor for the primary clinical journal of the Infectious Diseases Society of America--Clinical Infectious Diseases (CID).
Dr. Josh Hill is an Associate Professor at the Fred Hutchinson Cancer Center and the University of Washington (UW) in the Vaccine and Infectious Disease Division. His NIH-funded research program is focused on studies to improve preventive and treatment strategies for viral and other infections in immunocompromised patients.
By viewing the material on this site you understand and accept that: